Share information

Share information

Guard Therapeutics International AB is listed on Nasdaq First North Growth Market since 20 June 2017. The share is traded under the ticker GUARD (ISIN code: SE0021181559). Before that date, the company was listed on Aktietorget since 3 April 2013. On 30 September 2024, the share capital amounts to SEK 12,055,988.00 SEK divided by 12,055,988 shares forming one single series. During September a rights issue of 238,890 new shares was carried out. After the registration of the new shares, on 4 October, the share capital amounts to SEK 12,294,878.00 SEK divided by 12,294,878 shares. All shares have a quota value of SEK 1.00, each share entitles to one vote and an equal claim on the company's assets and profits. In December 2023, a consolidation of shares (a so-called reverse split) was carried out in a ratio of 1:50, this meant that 50 shares were merged into 1 share. The share capital remained unchanged.

Nasdaq First North Growth Market
Nasdaq First North Growth Market is an alternative stock exchange, operated by the different exchanges within NASDAQ OMX. It does not have the same legal status as a regulated market. Companies on Nasdaq First North Growth Market are subject to the rules of Nasdaq First North Growth Market and not the legal requirements for admission to trading on a regulated market. An investment in a company traded on Nasdaq First North Growth Market is riskier than a company traded on a regulated market. All companies whose shares are traded on Nasdaq First North Growth Market have a Certified Adviser to oversee compliance with the rules of Nasdaq First North Growth Market regarding information disclosure to investors and the market. A Certified Adviser oversees companies which are to be listed on Nasdaq First North Growth Market.

Dividend
All shares are entitled to the same dividend. Distribution of dividend, if any, is decided by the Annual General Meeting and paid thereafter. Payment of dividend is processed by Euroclear Sweden AB. Normally, withholding tax is deducted from dividend payments by Euroclear, or, in the case of nominee-registered shares, in accordance with each nominee’s procedures. In the event that distribution of dividend is decided, shareholders that are recorded in the shareholder register maintained by Euroclear on the record date determined at the Annual General Meeting are entitled to payment. In the event of liquidation, shareholders are entitled to a share in the surplus in proportion to the number of shares they own. Should a shareholder be unreachable through Euroclear, the shareholder’s claim on the company regarding dividend amounts will remain and only be restricted by limitation regulations. At the end of the limitation period, the dividend amount will accrue to the company.

There are no restrictions or special procedures pertaining to dividends for shareholders not resident in Sweden. Payment is processed by Euroclear in the same way as for shareholder's resident in Sweden. Shareholders that are not tax resident in Sweden will, however, be subject to the ordinary Swedish withholding tax.

According to the Swedish Companies Act, a shareholder with control over more than 90 percent of the shares is entitled to acquire the remaining outstanding shares through a compulsory acquisition procedure. The minority shareholders have a corresponding right to have their shares redeemed by the majority shareholder.

The company is subject to the Swedish Corporate Governance Board's rules concerning mandatory bids and public offers to shareholders in companies listed on Nasdaq First North Growth Market (Takeover Rules for Certain Trading Platforms). According to these rules, a shareholder whose ownership reaches or exceeds 30 percent of the votes is required to make a public offer to acquire all outstanding shares of the company.

.Shareholders:

Shareholder list per 30 September 2024. (Excluding BTA from the Rights Issue)